TARUGI, Patrizia Maria
 Distribuzione geografica
Continente #
NA - Nord America 18.855
AS - Asia 7.981
EU - Europa 7.370
SA - Sud America 1.067
Continente sconosciuto - Info sul continente non disponibili 204
AF - Africa 150
OC - Oceania 27
Totale 35.654
Nazione #
US - Stati Uniti d'America 18.497
SG - Singapore 2.511
GB - Regno Unito 2.462
CN - Cina 2.075
IT - Italia 1.766
HK - Hong Kong 1.006
BR - Brasile 816
VN - Vietnam 782
SE - Svezia 730
DE - Germania 538
BD - Bangladesh 413
FI - Finlandia 395
UA - Ucraina 338
RU - Federazione Russa 310
FR - Francia 283
KR - Corea 223
TR - Turchia 194
IN - India 193
CA - Canada 168
BG - Bulgaria 146
ID - Indonesia 118
NL - Olanda 95
MX - Messico 80
AR - Argentina 75
IQ - Iraq 65
JP - Giappone 62
PK - Pakistan 57
BE - Belgio 51
AE - Emirati Arabi Uniti 42
ES - Italia 40
CO - Colombia 38
ZA - Sudafrica 34
EC - Ecuador 31
IE - Irlanda 31
CL - Cile 27
PL - Polonia 27
VE - Venezuela 26
AU - Australia 25
AT - Austria 24
CR - Costa Rica 24
UZ - Uzbekistan 23
KE - Kenya 21
MY - Malesia 21
CH - Svizzera 19
JM - Giamaica 19
SA - Arabia Saudita 19
PH - Filippine 18
DZ - Algeria 17
EG - Egitto 17
CZ - Repubblica Ceca 16
PE - Perù 16
TN - Tunisia 16
TW - Taiwan 16
EU - Europa 15
IR - Iran 15
KZ - Kazakistan 15
LT - Lituania 15
NP - Nepal 15
BZ - Belize 14
MA - Marocco 14
PY - Paraguay 14
BA - Bosnia-Erzegovina 13
PT - Portogallo 12
UY - Uruguay 12
JO - Giordania 11
BO - Bolivia 10
ET - Etiopia 10
HU - Ungheria 10
IL - Israele 10
TH - Thailandia 10
TT - Trinidad e Tobago 10
AZ - Azerbaigian 9
AL - Albania 8
DO - Repubblica Dominicana 8
BH - Bahrain 7
GT - Guatemala 7
NI - Nicaragua 7
OM - Oman 7
LK - Sri Lanka 6
PS - Palestinian Territory 6
SV - El Salvador 6
DK - Danimarca 5
GE - Georgia 5
GR - Grecia 5
HN - Honduras 5
KG - Kirghizistan 5
KW - Kuwait 5
MD - Moldavia 5
PR - Porto Rico 5
SI - Slovenia 5
BB - Barbados 4
QA - Qatar 4
RO - Romania 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
EE - Estonia 3
KH - Cambogia 3
BY - Bielorussia 2
CG - Congo 2
GY - Guiana 2
Totale 35.429
Città #
Ashburn 2.104
Southend 1.766
Fairfield 1.668
Singapore 1.621
Santa Clara 1.572
Woodbridge 1.149
San Jose 1.013
Hong Kong 982
Houston 902
Jacksonville 709
Hefei 700
Chandler 664
Seattle 643
Wilmington 616
Ann Arbor 528
Cambridge 490
Council Bluffs 406
Dearborn 403
Nyköping 396
Beijing 367
London 357
Los Angeles 286
Helsinki 282
Modena 253
Ho Chi Minh City 243
Milan 216
Chicago 213
Seoul 209
The Dalles 209
New York 199
Hanoi 175
San Diego 154
Princeton 149
Sofia 139
Columbus 136
Buffalo 130
Rome 121
Dallas 119
Eugene 110
Lauterbourg 107
Reading 101
Moscow 96
Salt Lake City 89
São Paulo 89
Shanghai 87
Jakarta 81
Izmir 74
Boardman 70
Des Moines 69
Falls Church 61
Naples 53
Phoenix 52
Grafing 51
Brooklyn 47
Orem 47
Washington 47
Da Nang 46
Toronto 46
Elk Grove Village 45
Munich 43
Atlanta 41
Frankfurt am Main 40
Bremen 39
Tokyo 38
Rio de Janeiro 37
Brussels 35
Mexico City 33
Tampa 31
Nanjing 29
Redwood City 29
Dublin 28
Detroit 27
Bologna 26
Miano 26
Haiphong 24
Montreal 24
Baghdad 23
Chennai 23
Guangzhou 23
Kunming 23
Verona 23
Nuremberg 22
Turin 22
Norwalk 21
San Francisco 21
Tashkent 21
Belo Horizonte 20
Philadelphia 20
Miami 19
Palermo 19
San Mateo 19
Charlotte 18
Florence 18
Kent 18
Lahore 18
Manchester 18
Padova 18
Paris 18
Biên Hòa 17
Kilburn 17
Totale 24.786
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.228
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 542
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 503
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 481
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol 415
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 406
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 386
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 380
ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum(PXE). 378
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 372
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 371
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 367
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 366
Altered mRNA splicing in lipoprotein disorders 365
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 361
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 360
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 353
The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations 348
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 338
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 336
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 336
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 334
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 333
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins. 331
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 330
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 328
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 328
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 328
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 323
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 320
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 320
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 319
Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia 319
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 314
Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects 313
Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B 312
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 310
Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis 308
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 303
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 302
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 298
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 296
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia. 294
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 293
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 288
Pediatric gallstone disease in familial hypobetalipoproteinemia 287
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 284
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 284
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 283
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 281
Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia 279
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 274
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 273
A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia. 270
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 269
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia. 269
A 54-year-old diabetic man with low serum cholesterol. 266
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 264
PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia 263
Plasma non-cholesterol sterols in primary hypobetalipoproteinemia. 263
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 262
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 262
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations 262
Influence of chondroitin sulfate charge density, sulfate group position, and molecular mass on Cu2+-mediated oxidation of human low-density lipoproteins: Effect of normal human plasma-derived chondroitin sulfate 258
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 258
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia. 256
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 255
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide 252
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 250
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 248
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 248
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 247
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 247
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 246
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 246
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 243
Synthesis and secretion of apolipoprotein A-I by chick skin. 243
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 240
Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up. 239
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 239
The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure 237
Characterization of a mutant form of human apolipoprotein B (Thr26_Tyr27del) associated with familial hypobetalipoproteinemia 233
Novel mutations of SAR1B gene in four children with chylomicron retention disease 233
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 232
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 229
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 228
Exome Sequencing in Suspected Monogenic Dyslipidemias 228
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome 226
Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function 226
Cholesterol synthesis in freshly isolated human leukocytes. 225
Phenotypic expression of heterozygous familial hypobetalipoproteinemia in three kindreds with novel mutations of apolipoprotein B gene 225
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 224
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. 221
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 220
Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene. 220
Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. 217
Mutation screening of the Otop1 gene in familial benign positional paroxysmal vertigo 215
Dyslipidemia in rats with hypothyroidism 211
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 211
Abetalipoproteinemia in an infant with severe clinical phenotype and a novel mutation 209
Totale 30.116
Categoria #
all - tutte 140.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.919 0 0 0 191 56 213 151 106 282 215 454 251
2022/20232.204 257 218 159 179 252 351 40 196 294 46 131 81
2023/20241.654 73 83 149 147 301 148 131 187 74 120 49 192
2024/20255.494 184 50 118 376 1.049 849 444 333 501 241 612 737
2025/202610.645 726 466 932 1.027 1.527 741 1.346 553 951 1.019 749 608
2026/20272.478 449 630 779 620 0 0 0 0 0 0 0 0
Totale 35.654